Top 50 Ai For Genomics in Latin America

Onc.AI develops an AI-powered clinical management platform that utilizes a comprehensive oncology real-world dataset, including diagnostic imaging and genomics, to enhance treatment decision-making for metastatic lung cancer patients undergoing PD-1 immunotherapy. The platform provides actionable insights that enable oncologists to improve patient outcomes by optimizing treatment strategies based on real-world evidence.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

The startup specializes in identifying bioactive ribonucleic acid (RNA) from natural sources using machine learning and bioinformatics techniques. This enables researchers to enhance human health and resilience in response to environmental stressors through the application of RNA technologies.

Nintx Next Innovative Therapeutics utilizes proprietary technologies such as xGIbiomics, which simulates the human gastrointestinal system, and GAIApath, an AI-driven analytics platform, to identify and develop plant-based therapies targeting multifactorial diseases. By leveraging Brazil's rich biodiversity, Nintx aims to create multi-target therapies that modulate human biological systems and the microbiome, addressing the limitations of traditional single-target drug approaches.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

Biotango utilizes genomic editing and climate data analysis to enhance the productivity and quality of fruit crops, addressing the significant food waste and economic losses in agriculture. By predicting crop behavior under varying climatic conditions, the company aims to improve yield efficiency and reduce losses in fruit production by up to 30%.

The startup develops personalized pharmaceutical technology that tailors medication regimens based on individual patient profiles, enhancing therapeutic efficacy and minimizing adverse effects. By utilizing advanced data analytics and pharmacogenomics, the company aims to improve patient outcomes and overall quality of life.

Onward Assist is a predictive analytics platform that utilizes AI-driven image analysis to enhance cancer diagnosis by identifying biomarkers and reducing reporting time by 30-40%. The platform addresses the lack of effective cancer scoring tools tailored for diverse populations, enabling pathologists to make more accurate treatment decisions efficiently.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

metaBIX Biotech has developed a platform that utilizes hardware, biotechnology, and artificial intelligence to monitor airborne pathogens, providing early warnings of potential disease outbreaks in plants, animals, and humans. This technology enables clients to implement preventive measures at least two weeks before an outbreak occurs, enhancing safety and public health.

Elegen utilizes proprietary cell-free DNA synthesis technology to produce long, complex, linear DNA up to 7 kb with 99.999% accuracy, eliminating the need for cloning. This rapid synthesis, delivered in 6 to 8 business days, addresses the critical bottleneck in DNA supply for synthetic biology applications, significantly reducing project timelines and costs.

VivaWell provides a digital health and wellness platform that uses AI and data science to deliver personalized health programs and quality healthcare. It helps individuals and organizations improve health outcomes and manage healthcare costs through tailored services and population health insights.

Cache DNA is developing a wet operating system for the storage and retrieval of biomolecules, utilizing scalable nucleic acid storage techniques to preserve biological data indefinitely. This technology addresses the challenge of data loss by enabling the long-term retention of both digital and biological information without the need for deletion.

Provides data science, machine learning, and artificial intelligence consulting to help organizations in Colombia and LATAM leverage data for improved decision-making, operational efficiency, and cost reduction. Specializes in developing predictive models, optimizing processes, and implementing AI strategies tailored to industries such as healthcare, finance, agriculture, and retail.

Ambient Scientific develops the GPX10, an ultra-low power AI microprocessor designed for on-device applications, enabling years of operation on a single coin cell battery. This technology addresses the limitations of cloud dependency by providing efficient, always-on AI capabilities for battery-powered edge devices, enhancing data privacy and reducing operational costs.

DeepAgro utilizes generative AI for real-time weed detection and selective spraying, significantly reducing agrochemical usage by up to 90% based on weed density in soybean crops. Their platform also integrates agricultural data, enabling farmers to monitor crop health and optimize resource allocation efficiently.

Munai develops AI algorithms for hospitals and insurance providers to enhance patient management and reduce healthcare costs. Their platform enables efficient patient monitoring and data analysis, leading to improved clinical decision-making and significant cost savings.

The startup is developing a Clinical Digital Twin Platform that creates virtual replicas of patients using real-time health data and advanced modeling techniques. This platform enables healthcare providers to personalize treatment plans and improve patient outcomes by simulating various clinical scenarios.

Beeing Company utilizes artificial intelligence and neural networks to perform genetic analysis of honey bee queens, ensuring the preservation of bee species and promoting biodiversity. Their certification process guarantees that beekeepers can verify the quality and health of their bees, facilitating access to international markets.

Serena offers an AI-enabled platform that monitors lifestyle factors to identify early signs of chronic diseases, enabling proactive health management for individuals, employers, and healthcare providers. By providing actionable insights, Serena helps reduce healthcare costs and improve overall well-being through targeted interventions in nutrition, physical activity, and mental health.

Gennie is a generative AI platform that accelerates the product development process by over 10 times, utilizing advanced methodologies in Design Thinking and innovation processes. It addresses the lengthy time-to-market challenge by refining concepts early in the development cycle, enabling businesses to validate ideas more efficiently.

TAXON utilizes artificial intelligence and genomic analysis to enhance soil microbiome understanding, enabling farmers and biotech companies to optimize crop yields and reduce reliance on agrochemicals. By providing detailed insights into microbial diversity and functionality, TAXON helps clients make informed decisions that lead to sustainable agricultural practices and improved productivity.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

Rosebud Biosciences develops targeted therapies for rare genetic diseases in children by utilizing organoids that replicate specific genetic mutations, allowing for precise drug screening. This approach addresses the critical lack of approved treatments for 95% of rare diseases, significantly improving the potential for effective cures.

Genloops provides enterprises with customized large language models (LLMs) that are privately hosted on their infrastructure, significantly reducing costs by up to 90% compared to traditional GPT-4 usage. The platform enables seamless integration of tailored LLMs into existing workflows, ensuring data privacy and high-performance solutions that adapt to specific business needs.

BioHeuris combines synthetic biology and gene editing to create herbicide-resistant crops that enable sustainable weed management. This approach reduces the reliance on toxic herbicides and mitigates the evolution of herbicide-resistant weeds, promoting environmental sustainability in agriculture.

This agricultural bioscience company develops gene identification and characterization technologies to enhance crop yields and improve food security. By validating discoveries in prototype plants and forming partnerships with seed companies, they enable clients to maintain agricultural productivity amid climate challenges.

Aperture Therapeutics develops a drug discovery engine that utilizes extensive cell libraries representing genetic diversity to identify gene variants that confer protection against neurodegenerative diseases. By targeting specific RNA transcripts, the company aims to create therapies that can delay brain aging and improve outcomes for affected populations.

Neocrop Technologies accelerates crop improvement using its Neotrait Engine®, which combines CRISPR gene editing, speed-breeding, and proprietary software to rapidly develop new seed varieties. The platform delivers traits like drought tolerance and enhanced nutrition, significantly shortening the breeding cycle for commercial partners.

The startup has developed a molecular testing platform that utilizes low-cost tools for on-site analysis of DNA, RNA, and protein targets. This technology enables businesses to make real-time decisions regarding food quality and health by providing precise and accessible testing services.

Kinzbio develops precision antimicrobial therapies using bacteriophages to target and eliminate specific bacterial pathogens. Their AI-driven platform rapidly identifies and optimizes phages for personalized treatments, offering a highly specific alternative to traditional antibiotics.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

Yeda Health utilizes artificial intelligence to provide personalized dietary and lifestyle recommendations based on individual responses to food and continuous glucose monitoring data. This approach addresses the challenge of managing blood glucose levels by recognizing that each person's metabolic response is unique, enabling tailored strategies for metabolic stability.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

GenAI is a platform that utilizes natural language processing to analyze customer feedback and extract actionable insights. By transforming unstructured data into structured information, it enables businesses to understand customer sentiment and improve their products and services.

The startup offers a healthcare platform that utilizes artificial intelligence and data mining to enhance treatment management for patients and medical providers. By enabling patients to identify specialists and appropriate treatments, the platform improves diagnostic analysis and user experience, ultimately reducing the time and resources required for patient care.

Begen is a platform that connects businesses with specialized AI developers, enabling efficient access to AI solutions while reducing development costs. It addresses the challenge of AI adoption by providing a controlled environment for companies to implement AI-driven innovations and streamline their operations.

AIMedic utilizes artificial intelligence to integrate diverse medical data sources, enhancing diagnostic accuracy and treatment selection for healthcare professionals. The platform supports patient monitoring through an intelligent assistant, providing validated educational resources and vital health updates to improve patient outcomes.

This healthcare platform uses AI to analyze a patient's complete medical history, including medications and exam results, to generate intelligent diagnostic hypotheses. It helps medical professionals formulate accurate diagnoses by feeding patient characteristics into an algorithm, streamlining the diagnostic process.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

The startup develops a blood collection device that enables users to self-collect samples and send them for analysis. Utilizing dried plasma separation technology and medical algorithms, the company provides accurate health risk assessments based on individual health data, family history, and lifestyle factors.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

The startup develops gene therapies utilizing a biocompatible delivery system to facilitate targeted treatment of genetic diseases. This approach enhances the efficacy of therapeutic interventions, addressing the limitations of traditional treatment methods in the biotechnological market.

The startup develops AI-powered applications that enhance decision-making by analyzing large datasets and providing actionable insights. This technology enables organizations to make data-driven choices more efficiently, reducing uncertainty and improving operational outcomes.

Scout has developed a nucleic acid testing platform that utilizes patented technology to deliver lab-grade diagnostic tests at home, schools, and offices with results available in 30 minutes. This system addresses the inaccessibility and low accuracy of traditional home health tests by providing a more sensitive and accurate alternative, achieving 99% accuracy compared to lab tests.

The startup utilizes a proprietary Generative Biology Platform and a Discovery Platform that integrate machine learning and multi-modal single-cell analysis to identify gene regulatory networks and develop targeted cell therapies for cancer. By precisely modulating gene expression in specific cell types, the company aims to enhance the efficacy of cell-based treatments, addressing the limitations of traditional cancer therapies.

Naturannova utilizes a computational platform that combines AI and bioinformatics to identify and analyze plant-based proteins, creating sustainable and clean label ingredients. The startup addresses the need for healthier food options by developing novel protein sources, such as their all-natural protein-based sweetener, through precision fermentation and laboratory testing.